Nanalysis Scientific (CVE:NSCI) Hits New 1-Year Low – Time to Sell?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report)’s share price hit a new 52-week low on Tuesday . The company traded as low as C$0.16 and last traded at C$0.17, with a volume of 598249 shares. The stock had previously closed at C$0.18.

Nanalysis Scientific Stock Down 8.3%

The firm’s 50 day simple moving average is C$0.19 and its 200 day simple moving average is C$0.22. The company has a market cap of C$18.95 million, a price-to-earnings ratio of -1.50 and a beta of -0.82. The company has a quick ratio of 1.11, a current ratio of 1.42 and a debt-to-equity ratio of 71.72.

Nanalysis Scientific Company Profile

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Read More

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.